Plunkett Research Online: 4SC AG

4SC AG (FSCGF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

4SC AG is a German-based drug discovery and development company that focuses on possible treatments for autoimmune diseases and cancer. The company develops its compounds to the clinical phase, after which they are licensed to the biopharmaceutical industry for further testing, development and comm.....



4SC AG
Ticker: FSCGF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 49-897007630
Fax: 49-8970076329
Address: Fraunhoferstrasse 22
Planegg-Martinsried, 82152 Germany

Types Of Business
Industry Ranks

Industry NAICS code:

Drug Discovery & Pre-Clinical Development
Drugs-Oncology
Drugs-Inflammation
Drugs-Autoimmune Diseases
High Throughput Screening
ContactsDescription

Jason LoveridgeCEO/Chmn.
Daniel VittChief Science Officer
See More
4SC AG is a German-based drug discovery and development company that focuses on possible treatments for autoimmune diseases and cancer. The company develops its compounds to the clinical phase, after which they are licensed to the biopharmaceutical industry for further testing, development and comm.....See More See More

Auditor: Baker Tilly
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Resminostat
Domatinostat
4SC-202
SENSITIZE
4SC-208
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: